Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetes

Key Points

Key points are not available for this paper at this time.

Abstract

Dapagliflozin-induced SGLT2 inhibition for 12 weeks is associated with reductions in 24-h BP, body weight, GFR and possibly plasma volume. Cumulatively, these effects suggest that dapagliflozin may have a diuretic-like capacity to lower BP in addition to beneficial effects on glycaemic control.

Read Full Paperexternally

Bookmark

View Full Paper

Bookmark

View Full Paper

Cite This Study

Heerspink et al. (Mon,) studied this question.

synapsesocial.com/papers/69d7f43ea2a48916bbbee7f8 https://doi.org/https://doi.org/10.1111/dom.12127

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Comparison of Fixed-dose Rosiglitazone/Metformin Combination Therapy with Sulphonylurea Plus Metformin in Overweight Individuals with Type 2 Diabetes Inadequately Controlled on Metformin Alone2007 · 49 citations